Connect your AI

Pulse Biosciences, Inc. PLSE Price / book

Price / book at other companies

AbbottABT

3.4×-1.3×

Johnson & JohnsonJNJ

7.3×+2.1×

Boston ScientificBSX

3.6×-3.1×

MedtronicMDT

2.1×-0.1×

Merit Medical SystemsMMSI

2.5×-1.8×

ITG

Integer HoldingsITGR

1.8×-0.8×

Other financials

Income statement

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

Market cap$1.8B+38.4%

Enterprise value$1.73B+48.1%

P/S2,391.5×—

Profitability

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

market cap/total stockholders equity=22.1×

Based on the most recent quarter.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pulse Biosciences, Inc.'s price / book?: Pulse Biosciences, Inc. (PLSE) reported price / book of 22.1× in Q1 2026.
How has Pulse Biosciences, Inc.'s price / book changed year-over-year?: Pulse Biosciences, Inc.'s price / book increased by 147.2% year-over-year, from 9× to 22.1×.
What is the long-term trend for Pulse Biosciences, Inc.'s price / book?: Over 4 years (2020 to 2025), Pulse Biosciences, Inc.'s price / book has grown at a -19.3% compound annual growth rate (CAGR), from 27.2× to 11.5×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.